John J. Park, M.D., Ph.D.
Interventional Radiologist
(8 RATINGS)
Clinical Expertise
Interventional Radiology
Treatment of Vascular Disorders: Arterial Disorders, Venous Disorders, and Congenital Vascular Malformations
Image-Guided Cancer Therapies: Liver, Lung, Kidneys, Bone, Adrenal, and Soft Tissue Cancers
Men’s Health: Benign Prostate Disorders and Varicocele Treatment
Women’s Health: Uterine Fibroids, Pelvic Congestion, and Varicose Veins
Interventional Pain Management
Appointments
Division Chief, Interventional Radiology
Associate Clinical Professor, Department of Diagnostic Radiology
Clinical Teams
John J. Park, M.D., Ph.D., is the Chief of the Division of Interventional Radiology,which was established at City of Hope in 2011. Over the years he has built the Division into a nationally-recognized program centered around a culture of high-quality patient care, clinical excellence and forward-minded research.
As a Board Certified and Fellowship Trained Interventional Radiologist, Dr. Park is interested in the treatment of diseases using minimally-invasive, image-guided techniques. This includes the development of clinical practices and the implementation of novel treatment paradigms for both vascular and oncologic diseases. As a physician-scientist, Dr. Park is also interested in understanding disease states. He is actively focused on conducting translation research that will ultimately help in better understanding and treating cancer and related conditions through the development of new technologies and targeted therapies.
As a Board Certified and Fellowship Trained Interventional Radiologist, Dr. Park is interested in the treatment of diseases using minimally-invasive, image-guided techniques. This includes the development of clinical practices and the implementation of novel treatment paradigms for both vascular and oncologic diseases. As a physician-scientist, Dr. Park is also interested in understanding disease states. He is actively focused on conducting translation research that will ultimately help in better understanding and treating cancer and related conditions through the development of new technologies and targeted therapies.
Dr. Park is highly experienced in many minimally-invasive, image-guided interventions, including but not limited to:
Interventional Radiology/Interventional Oncology
- Angiography, Angioplasty and Vascular Stenting
- Biopsies and Fiducials
- Catheter-directed Thrombolysis and Vessel Recanalization for Deep Venous Thrombosis, Pulmonary Emboli, Superior Vena Cava Syndrome, and other Venothrombotic Diseases
- Chest Interventions (Pleurx drains, Tumor Ablations, Biopsies)
- Focal Ablation of Soft Tissue and Bone Tumors – Microwave/RFA, Cryoablation, NanoKnife (Liver, Lung, Kidneys, Pancreas, Bones, Adrenals, etc.)
- Genitourinary Interventions (Nephrostomy tubes, Ureteral Stents, Tumor Embolizations, Kidney Tumor Ablation, Prostate Interventions)
- Inferior Vena Cava Filter Placement and Removal
- Liver and GI Interventions (Ablations, Y90 Radioembolizations, Embolizations, Chemoembolizations, Biliary Interventions, Transvenous Obliteration of Varices)
- Men’s Health – Varicoceles, Benign Prostate Hyperplasia Treatment (PAE)
- Pain Management – Neurolytic Celiac Plexus, Nerve Root and Epidural Blockade
- Percutaneous Abscess Drainage
- Peritoneal Ports and PleurX Drainage Catheters for Ascites/Effusions
- Spine and Bone Interventions (Vertebroplasty. Kyphoplasty, Bone Ablation, Cementoplasty)
- Vascular Access Procedures (Tunneled Catheters, Ports, Central Lines)
- Vascular Diseases (Claudication, Arterial or Venous Occlusions)
- Women’s Health (Uterine fibroid Embolizations, P:elvic Congestion Syndrome)
Dr. Park received his undergraduate degree at the University of California, Berkeley, his medical and doctorate degrees from the Keck School of Medicine of the University of Southern California and completed his radiology residency and interventional radiology fellowship training at the University of California, Los Angeles Medical Center.
2011, Vascular & Interventional Radiology CAQ
2007, American Board of Radiology, Diplomate
2003, Medical Board of California
1994 - 2002, University of Southern California Keck School of Medicine, Los Angeles, CA. M.D., Ph.D., Pathobiology
2007 -2008, University of California, Los Angeles Medical Center, Geffen School of Medicine, Los Angeles, CA, Fellowship, Interventional Radiology
2003 - 2007, University of California, Los Angeles Medical Center, Geffen School of Medicine, Los Angeles, CA, Resident, Department of Radiology
2002 - 2003, University of Southern California Keck School of Medicine, Los Angeles, CA, Intern, Department of Urology/Surgery
Contributions to Science
1. Investigating ablative technologies in the treatment of cancer. Specifically, Dr. Park is interested in developing and evaluating innovations in minimally-invasive tumor targeting and treatments utilizing novel delivery and treatment monitoring platforms, such as tele-navigation, robotics, and fusion imaging. Through collaborations with both clinical and industry partners, Dr. Park has engaged in prospective and retrospective studies focused on improving technical and clinical outcomes during percutaneous image-guided oncologic interventions.
a.) Schena, E., Giurazza, F., Massaroni, C., Fong, Y., Park, J. J., & Saccomandi, P. (2017, May). Thermometry based on computed tomography images during microwave ablation: Trials on ex vivo porcine liver. In Instrumentation and Measurement Technology Conference (I2MTC), 2017 IEEE International (pp. 1-6).
b.) Schena, E., Massaroni, C., Giurazza, F., Park, J., Park, J., Fong, Y., & Saccomandi, P. (2016, September). Feasibility Assessment and Analysis of Thermal Sensitivity of CT-Thermometry During Microwave Ablation of Ex Vivo Porcine Kidneys. In 2016 Nanotechnology for Instrumentation and Measurement (NANOfIM) (pp. 5-16). IEEE.
c.) John Park MD PhD, Jonathan Kessler, MD, Aram Lee MD. Early Safety and Effectiveness of Early Safety and Effectiveness of Thermosphere Microwave Ablation (Emprint) in the Percutaneous Treatment of Perivascular Liver Tumors. World Conference of Interventional Radiology, Boston, MA, 2016 Poster presentation.
2. Treating liver tumors utilizing transcatheter based therapies. Intrahepatic progression of liver tumors is a challenging process to treat and is associated with poor prognosis when present. In multidisciplinary collaborative efforts, Dr. Park is working with his oncologic colleagues in better understanding and developing rationale combination approaches in treating liver cancers by incorporating multiple combined platforms. Dr. Park has been highly involved in both investigator initiated and multi-center randomized control trials in evaluating the use of transcatheter based liver-directed therapies along with surgical interventions and/or systemic therapies.
a.) Jonathan Kessler, MD and John J Park, MD, PhD. Yttrium-90 Radioembolization After Local Hepatic Therapy: How Prior Treatments Impact Patient Selection, Dosing, and Toxicity. Techniques in Vascular & Interventional Radiology , Volume 0 , Issue 0 (ePUB, In Press, 2019)
b.) A single institute retrospective trial of concurrent chemotherapy with SIR-Spheres® versus SIR-Spheres® alone in chemotherapy-resistant colorectal cancer liver metastases, Cho M, Kessler J, Park JJ, Lee A, Gong J, Singh G, Chen YJ, Ituarte PHG, Fakih M, J Gastrointest Oncol, Aug 2017, v.8(4): 6008-613
c.) Radioembolization Following Major Liver Resection: Safety and Dosing Considerations, Kessler J, Lewis A, Gagandeep S, Ituarte PH, Park JJ. J Vasc Interv Radiol. 2016 Jan; 27(1):46-51.
d.) The Evolution of Liver Directed Treatments for Hepatic Colorectal Metastases, Park J, Chen YJ, Lu WP, Fong Y. Oncology 28(11): 991-1003, 2014.
3. Improving embolization techniques for the treatment of vascular and non-vascular disorders. Dr. Park is interested in developing therapeutic (embolic and non-embolic) platforms for the treatment of various disorders. As therapeutic devices continue to evolve, identifying how these devices can be utilized in novel applications is important in establishing best practices for treating challenging disorders. Dr. Park has ongoing collaborations with academic and industry partners in developing, evaluating and improving various therapeutic platforms, including bland embolization devices, drug eluting devices, and other non-traditional platforms. By using direct tissue targeting techniques like percutaneous needle injection or trans-catheter delivery of an embolic and/or therapeutic payload, more selective, and possibly more effective, treatments can be achieved.
a.)Reduced Metal Artifacts on CT Utilizing the Medtronic MVP Microvascular Plug System, John J Park and Jinha M Park, Endovascular Today, Oct 2017, v.16: 31-33.
b.)Minimally Invasive Interventions for Nontraumatic Splenic Disorders, Lee A, Kessler J, Park JM, Fatemi N, and Park JJ, Endovascular Today, Feb 2017, v.16: 77-84.
c.)Outcomes of Salvage Percutaneous Biliary Drainage after Occlusion of Endoscopic Stents, Kessler J, Lee A, Frankel P, Dagis A, Park JJ, and Lin J, JVIR, ePUB Mar 2017, v.27.
d.)Embolization of a Pulmonary Arteriovenous Malformation, John J. Park, Endovascular Today, Sept 2016, vol.15.
Society of Interventional Radiology
International Society for Magnetic Resonance in Medicine
Radiological Society of North America
American Roentgen Ray Society
Board of Trustees, American Medical Students Association
USC Chapter of the American Medical Students Association
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.